Regenerative medicine and stem cell therapies

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

226 papers

Active filtersClassification:Core

Showing 37-48 of total 226 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedDirectly related

Successful Management of Severe Hepatic Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in a Child With β-Thalassemia Major: Clinical Lessons From Early Therapeutic Escalation.

2026PubMedDirectly related

Barriers and Blueprints: Next-Generation Engineering Strategies for CAR-T Cell Therapy in Gastrointestinal Tumors.

Ismail M; Al-Gizey N; Alabed Z; Mustafa N; Al-Najjar E; Hamdaneh Y; Eid N; Esmail A

Jan 1, 2026Pharmaceuticals (Basel, Switzerland)

2026PubMedDirectly related

Barriers and Blueprints: Next-Generation Engineering Strategies for CAR-T Cell Therapy in Gastrointestinal Tumors.

Ismail M; Al-Gizey N; Alabed Z; Mustafa N; Al-Najjar E; Hamdaneh Y; Eid N; Esmail A

Jan 1, 2026Pharmaceuticals (Basel, Switzerland)

2026PubMedDirectly related

The SPIZ study: rationale and protocol of a randomized controlled trial to optimize interdisciplinary care of patients following cellular therapy through a digitally supported, cross-regional and cross-sectoral care model.

Schneider MMK; Müller G; Herbst S; Slesaczeck J; Schmädig R; Schmidt F; Illmer T; Leppla L; Valenta S; De Geest S; Teynor A; Wolfien M; Ernst A; Bischof L; Schmitt J; Hänel M; Metzeler KH; Platzbecker U; Vučinić V; Schetelig J; Bornhäuser M; Middeke JM; Egger-Heidrich K

Jan 1, 2026Annals of hematology

2026PubMedDirectly related

The SPIZ study: rationale and protocol of a randomized controlled trial to optimize interdisciplinary care of patients following cellular therapy through a digitally supported, cross-regional and cross-sectoral care model.

Jan 1, 2026Annals of hematology

2026PubMedDirectly related

Hippo Pathway-YAP/TAZ Signaling: Molecular Mechanisms, Biological Function, Diseases, and Therapeutic Targets.

Qu X; Wang ZY

Jan 1, 2026MedComm

2026PubMedDirectly related

Extracellular Vesicles at the Interface of Cancer Therapy and Regenerative Medicine: Biology, Bidirectional Roles, and Engineered Therapeutics.

Jang JH

Jan 1, 2026Medical sciences (Basel, Switzerland)

2026PubMedDirectly related

A pilot phase IIa randomized, placebo-controlled, double-blind trial of intravenous human pluripotent adipose-derived stem cells (PASCs) in Parkinson's disease: The REPOSE study.

Gimeno ML; Chazenbalk G; Riggioni L; Ortega A; Miranda L; Valverde JA; Molina-Mora JA; Rojas LG; Vargas P; Zuñiga C; Rosales L; Henríquez F

Jan 1, 2026Cell transplantation

2026PubMedDirectly related

Beating the heart failure epidemic: can emerging cell therapies deliver what conventional approaches cannot?

Saltzman RG; Asensi KD; Chakraborty A; Kulandavelu S; Hare JM

Jan 1, 2026Expert review of cardiovascular therapy

2026PubMedDirectly related

Reporter-guided photoreceptor differentiation in 2D culture using PGP1-hIPSCs: A comparable alternative to 3D organoid systems?

Beaver D; Cioanca AC; Barnett NL

Jan 1, 2026Molecular vision

2026PubMedDirectly related

Optimizing alginate-based delivery systems to enhance adipose-derived stem cell functionality in regenerative medicine: a comprehensive review.

Ahmadi M; Atighi A; Aligol MS; Hashemi M; Kalalinia F

Jan 1, 2026Journal of biomaterials science. Polymer edition

2026PubMedDirectly related

Comparative evidence on the independent contribution of granulocyte-macrophage colony-stimulating factor to anti-GD2 immunotherapy in neuroblastoma: a systematic review and gap analysis.

Wieczorek A; Mielecka-Jarmocik G; Synakiewicz A; Śladowska K; Kawalec P; Lode HN

Jan 1, 2026Frontiers in oncology